Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

about

Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report.

P2860

Q49505118-6B2CBB77-7FD4-41DA-8F3D-5DA6B75E90F0

P2860

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

Item

http://www.wikidata.org/entity/Q42577593

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

@en

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

@nl

type

Item

label

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

@en

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

@nl

prefLabel

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

@en

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

@nl

P1476

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

@en

P2093

Shabnam Mehra

http://www.w3.org/2001/XMLSchema#string

Thomas J Mason

http://www.w3.org/2001/XMLSchema#string

P2860

The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension

Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.

Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.

Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure.

Hemodynamic effects of inhaled nitric oxide in heart failure.

A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.

Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients.

The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension.

The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.

Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.

P304

406-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2045-8932.113180

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maya Guglin

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256470443

http://www.w3.org/2001/XMLSchema#string

P698

24015342

http://www.w3.org/2001/XMLSchema#string

P932

3757836

http://www.w3.org/2001/XMLSchema#string

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

about

P2860

P2860

Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932